Improving the techniques for human hepatocyte transplantation

Report from a consensus meeting in London

Juliana Puppi, Stephen C. Strom, Robin D. Hughes, Sanjay Bansal, Jose V. Castell, Ibrahim Dagher, Ewa C S Ellis, Greg Nowak, Bo Goran Ericzon, Ira J. Fox, José M. Gómez-Lechón, Chandan Guha, Sanjeev Gupta, Ragai R. Mitry, Kazuo Ohashi, Michael Ott, Lola M. Reid, Jayanta Roy-Chowdhury, Etienne Sokal, Anne Weber & 1 others Anil Dhawan

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

On September 6 and 7, 2009 a meeting was held in London to identify and discuss what are perceived to be current roadblocks to effective hepatocyte transplantation as it is currently practiced in the clinics and, where possible, to offer suggestions to overcome the blocks and improve the outcomes for this cellular therapy. Present were representatives of most of the active clinical hepatocyte transplant programs along with other scientists who have contributed substantial basic research to this field. Over the 2-day sessions based on the experience of the participants, numerous roadblocks or challenges were identified, including the source of cells for the transplants and problems with tracking cells following transplantation. Much of the discussion was focused on methods to improve engraftment and proliferation of donor cells posttransplantation. The group concluded that, for now, parenchymal hepatocytes isolated from donor livers remain the best cell source for transplantation. It was reported that investigations with other cell sources, including stem cells, were at the preclinical and early clinical stages. Numerous methods to modulate the immune reaction and vascular changes that accompany hepatocyte transplantation were proposed. It was agreed that, to obtain sufficient levels of repopulation of liver with donor cells in patients with metabolic liver disease, some form of liver preconditioning would likely be required to enhance the engraftment and/or proliferation of donor cells. It was reported that clinical protocols for preconditioning by hepatic irradiation, portal vein embolization, and surgical resection had been developed and that clinical studies using these protocols would be initiated in the near future. Participants concluded that sharing information between the groups, including standard information concerning the quality and function of the transplanted cells prior to transplantation, clinical information on outcomes, and standard preconditioning protocols, would help move the field forward and was encouraged.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalCell Transplantation
Volume21
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Liver
Hepatocytes
Transplantation
Tissue Donors
Transplants
Cell Transplantation
Antigen-antibody reactions
Cell Proliferation
Transplantation (surgical)
Information Dissemination
Metabolic Diseases
Clinical Protocols
Portal Vein
Stem cells
Blood Vessels
Liver Diseases
Stem Cells
Irradiation
Research
Therapeutics

Keywords

  • Engraftment
  • Hepatocyte transplantation
  • Metabolic liver disease
  • Radiation
  • Stem cell

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

Puppi, J., Strom, S. C., Hughes, R. D., Bansal, S., Castell, J. V., Dagher, I., ... Dhawan, A. (2012). Improving the techniques for human hepatocyte transplantation: Report from a consensus meeting in London. Cell Transplantation, 21(1), 1-10. https://doi.org/10.3727/096368911X566208

Improving the techniques for human hepatocyte transplantation : Report from a consensus meeting in London. / Puppi, Juliana; Strom, Stephen C.; Hughes, Robin D.; Bansal, Sanjay; Castell, Jose V.; Dagher, Ibrahim; Ellis, Ewa C S; Nowak, Greg; Ericzon, Bo Goran; Fox, Ira J.; Gómez-Lechón, José M.; Guha, Chandan; Gupta, Sanjeev; Mitry, Ragai R.; Ohashi, Kazuo; Ott, Michael; Reid, Lola M.; Roy-Chowdhury, Jayanta; Sokal, Etienne; Weber, Anne; Dhawan, Anil.

In: Cell Transplantation, Vol. 21, No. 1, 2012, p. 1-10.

Research output: Contribution to journalArticle

Puppi, J, Strom, SC, Hughes, RD, Bansal, S, Castell, JV, Dagher, I, Ellis, ECS, Nowak, G, Ericzon, BG, Fox, IJ, Gómez-Lechón, JM, Guha, C, Gupta, S, Mitry, RR, Ohashi, K, Ott, M, Reid, LM, Roy-Chowdhury, J, Sokal, E, Weber, A & Dhawan, A 2012, 'Improving the techniques for human hepatocyte transplantation: Report from a consensus meeting in London', Cell Transplantation, vol. 21, no. 1, pp. 1-10. https://doi.org/10.3727/096368911X566208
Puppi, Juliana ; Strom, Stephen C. ; Hughes, Robin D. ; Bansal, Sanjay ; Castell, Jose V. ; Dagher, Ibrahim ; Ellis, Ewa C S ; Nowak, Greg ; Ericzon, Bo Goran ; Fox, Ira J. ; Gómez-Lechón, José M. ; Guha, Chandan ; Gupta, Sanjeev ; Mitry, Ragai R. ; Ohashi, Kazuo ; Ott, Michael ; Reid, Lola M. ; Roy-Chowdhury, Jayanta ; Sokal, Etienne ; Weber, Anne ; Dhawan, Anil. / Improving the techniques for human hepatocyte transplantation : Report from a consensus meeting in London. In: Cell Transplantation. 2012 ; Vol. 21, No. 1. pp. 1-10.
@article{d9769c7bf5be4f129bf6e4e86d4384b4,
title = "Improving the techniques for human hepatocyte transplantation: Report from a consensus meeting in London",
abstract = "On September 6 and 7, 2009 a meeting was held in London to identify and discuss what are perceived to be current roadblocks to effective hepatocyte transplantation as it is currently practiced in the clinics and, where possible, to offer suggestions to overcome the blocks and improve the outcomes for this cellular therapy. Present were representatives of most of the active clinical hepatocyte transplant programs along with other scientists who have contributed substantial basic research to this field. Over the 2-day sessions based on the experience of the participants, numerous roadblocks or challenges were identified, including the source of cells for the transplants and problems with tracking cells following transplantation. Much of the discussion was focused on methods to improve engraftment and proliferation of donor cells posttransplantation. The group concluded that, for now, parenchymal hepatocytes isolated from donor livers remain the best cell source for transplantation. It was reported that investigations with other cell sources, including stem cells, were at the preclinical and early clinical stages. Numerous methods to modulate the immune reaction and vascular changes that accompany hepatocyte transplantation were proposed. It was agreed that, to obtain sufficient levels of repopulation of liver with donor cells in patients with metabolic liver disease, some form of liver preconditioning would likely be required to enhance the engraftment and/or proliferation of donor cells. It was reported that clinical protocols for preconditioning by hepatic irradiation, portal vein embolization, and surgical resection had been developed and that clinical studies using these protocols would be initiated in the near future. Participants concluded that sharing information between the groups, including standard information concerning the quality and function of the transplanted cells prior to transplantation, clinical information on outcomes, and standard preconditioning protocols, would help move the field forward and was encouraged.",
keywords = "Engraftment, Hepatocyte transplantation, Metabolic liver disease, Radiation, Stem cell",
author = "Juliana Puppi and Strom, {Stephen C.} and Hughes, {Robin D.} and Sanjay Bansal and Castell, {Jose V.} and Ibrahim Dagher and Ellis, {Ewa C S} and Greg Nowak and Ericzon, {Bo Goran} and Fox, {Ira J.} and G{\'o}mez-Lech{\'o}n, {Jos{\'e} M.} and Chandan Guha and Sanjeev Gupta and Mitry, {Ragai R.} and Kazuo Ohashi and Michael Ott and Reid, {Lola M.} and Jayanta Roy-Chowdhury and Etienne Sokal and Anne Weber and Anil Dhawan",
year = "2012",
doi = "10.3727/096368911X566208",
language = "English (US)",
volume = "21",
pages = "1--10",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "1",

}

TY - JOUR

T1 - Improving the techniques for human hepatocyte transplantation

T2 - Report from a consensus meeting in London

AU - Puppi, Juliana

AU - Strom, Stephen C.

AU - Hughes, Robin D.

AU - Bansal, Sanjay

AU - Castell, Jose V.

AU - Dagher, Ibrahim

AU - Ellis, Ewa C S

AU - Nowak, Greg

AU - Ericzon, Bo Goran

AU - Fox, Ira J.

AU - Gómez-Lechón, José M.

AU - Guha, Chandan

AU - Gupta, Sanjeev

AU - Mitry, Ragai R.

AU - Ohashi, Kazuo

AU - Ott, Michael

AU - Reid, Lola M.

AU - Roy-Chowdhury, Jayanta

AU - Sokal, Etienne

AU - Weber, Anne

AU - Dhawan, Anil

PY - 2012

Y1 - 2012

N2 - On September 6 and 7, 2009 a meeting was held in London to identify and discuss what are perceived to be current roadblocks to effective hepatocyte transplantation as it is currently practiced in the clinics and, where possible, to offer suggestions to overcome the blocks and improve the outcomes for this cellular therapy. Present were representatives of most of the active clinical hepatocyte transplant programs along with other scientists who have contributed substantial basic research to this field. Over the 2-day sessions based on the experience of the participants, numerous roadblocks or challenges were identified, including the source of cells for the transplants and problems with tracking cells following transplantation. Much of the discussion was focused on methods to improve engraftment and proliferation of donor cells posttransplantation. The group concluded that, for now, parenchymal hepatocytes isolated from donor livers remain the best cell source for transplantation. It was reported that investigations with other cell sources, including stem cells, were at the preclinical and early clinical stages. Numerous methods to modulate the immune reaction and vascular changes that accompany hepatocyte transplantation were proposed. It was agreed that, to obtain sufficient levels of repopulation of liver with donor cells in patients with metabolic liver disease, some form of liver preconditioning would likely be required to enhance the engraftment and/or proliferation of donor cells. It was reported that clinical protocols for preconditioning by hepatic irradiation, portal vein embolization, and surgical resection had been developed and that clinical studies using these protocols would be initiated in the near future. Participants concluded that sharing information between the groups, including standard information concerning the quality and function of the transplanted cells prior to transplantation, clinical information on outcomes, and standard preconditioning protocols, would help move the field forward and was encouraged.

AB - On September 6 and 7, 2009 a meeting was held in London to identify and discuss what are perceived to be current roadblocks to effective hepatocyte transplantation as it is currently practiced in the clinics and, where possible, to offer suggestions to overcome the blocks and improve the outcomes for this cellular therapy. Present were representatives of most of the active clinical hepatocyte transplant programs along with other scientists who have contributed substantial basic research to this field. Over the 2-day sessions based on the experience of the participants, numerous roadblocks or challenges were identified, including the source of cells for the transplants and problems with tracking cells following transplantation. Much of the discussion was focused on methods to improve engraftment and proliferation of donor cells posttransplantation. The group concluded that, for now, parenchymal hepatocytes isolated from donor livers remain the best cell source for transplantation. It was reported that investigations with other cell sources, including stem cells, were at the preclinical and early clinical stages. Numerous methods to modulate the immune reaction and vascular changes that accompany hepatocyte transplantation were proposed. It was agreed that, to obtain sufficient levels of repopulation of liver with donor cells in patients with metabolic liver disease, some form of liver preconditioning would likely be required to enhance the engraftment and/or proliferation of donor cells. It was reported that clinical protocols for preconditioning by hepatic irradiation, portal vein embolization, and surgical resection had been developed and that clinical studies using these protocols would be initiated in the near future. Participants concluded that sharing information between the groups, including standard information concerning the quality and function of the transplanted cells prior to transplantation, clinical information on outcomes, and standard preconditioning protocols, would help move the field forward and was encouraged.

KW - Engraftment

KW - Hepatocyte transplantation

KW - Metabolic liver disease

KW - Radiation

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=84863258782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863258782&partnerID=8YFLogxK

U2 - 10.3727/096368911X566208

DO - 10.3727/096368911X566208

M3 - Article

VL - 21

SP - 1

EP - 10

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 1

ER -